- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05730504
Evaluating the Effectiveness of Mobile Self-guided Psychological Interventions to Reduce Relapse in Substance Use Disorder
Evaluating the Effectiveness of a Mobile App-based Self-guided Psychological Interventions to Reduce Relapse in Substance Use Disorder: Protocol for a Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
The aim of the study is to evaluate the effectiveness of mobile interventions in reducing craving and lapses in patients diagnosed with Substance Use Disorder.
Participants will be recruited from clinical patients receiving either in-patient or out-patient treatments for Substance Use Disorder (SUD) and enrolled in one of three groups: 1) Patients with alcohol addiction, 2) Patients with cross-addiction (alcohol and stimulants), 3) Patients with cannabis addiction.
Participants will be randomly assigned to either intervention or control condition. The mobile interventions will be delivered via a mobile app Nałogometr 2.0, freely available. Participants in the intervention condition will have free access to all of the app functionalities, while the control group won't gain access to the interventions until after study completion.
Interventions consist of audio-guided, short sessions on gratitude, thoughts management, motivation, relaxation, audio-guided mindfulness sessions concentrated on raising awareness of emotions and body signals or coping with stress, as well as CBT-based written sessions grounded in thought management and journaling techniques.
With the use of ecological momentary assessment (EMA), longitudinal data on several variables related to craving and lapse risk will be collected. Additionally, a questionnaire battery assessment - administered at baseline, after one month, after two months, and after three months - will measure severity of substance dependence, levels of anxiety, depression, and life satisfaction.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Białystok, Poland, 15-668
- Recruiting
- PredictWatch
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosis of a Substance Use Disorder (SUD)
- addiction to either alcohol, cannabis, or cross-addiction (alcohol + stimulants)
- min. 18 years of age
- fluent polish speakers
- users of Android or IOS smartphones
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mobile app-based self-guided interventions
Participants have access to self-guided, app-based mobile psychological interventions grounded in Cognitive Behavioral Therapy, meditation, mindfulness, journaling, as well as audio-guided sessions on gratitude, thoughts management, auto-empathy, and relaxation
|
self-guided, app-based mobile psychological interventions based on CBT, meditation, mindfulness, journaling, and audio-guided sessions on gratitude, thoughts management, auto-empathy, and relaxation
|
|
No Intervention: No interventions
Participants don't have access to app-based mobile psychological interventions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of lapses
Time Frame: 3 months
|
self-reported number of lapses collected during daily Ecological Momentary Assessment - an item asking if the lapse occurred since the last survey (yes / no).
The frequency of lapses will be tracked for changes over time.
|
3 months
|
|
addiction craving
Time Frame: 3 months
|
self-reported intensity of craving collected during daily Ecological Momentary Assessment - an item asking how strong is the urge to use on a scale from 0 to 6, where 0 means no urge, and 6 - an overwhelming urge.
The score will be tracked for changes over time.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alcohol Use Disorder Identification Test (AUDIT) score
Time Frame: baseline, one month, two months, three months
|
Problematic alcohol use will be measured with an Alcohol Use Disorders Identification Test (AUDIT).
AUDIT assesses the amount and frequency of alcohol intake (items 1-3), alcohol dependence (questions 4-6), and problems related to alcohol consumption (items 7-10).
Questions 1 to 8 are scored on a 5-point scale ranging from 0 to 4, and questions 9 and 10 are scored as 0, 2, or 4. Total scores range from 0 to 40, and the cut-off point to identify hazardous alcohol intake is 8, a score between 16 and 19 indicates harmful alcohol use, and scores above 20 points indicate possible alcohol use disorder.
Participants will answer the questions in terms of standard drinks.
|
baseline, one month, two months, three months
|
|
Severity of Dependence Scale (SDS) score
Time Frame: baseline, one month, two months, three months
|
The Severity of Dependence Scale (SDS) will be used to provide a self-reported measure of psychological aspects of stimulants and alcohol dependence.
A five-items, one-dimensional tool has uniform scale for questions 1 - 4 from 0 ('never or almost never') to 3 ('always').
Question 5 has the same scale with different signature where 0 means 'not difficult at all' and 3 means 'impossible'.
Score ranging from 0 to 15, where cut-off score depends on user's drug type - a cut-off of =< 3 has been used for indexing alcohol dependence and =< 5 for indexing amphetamine dependence.
|
baseline, one month, two months, three months
|
|
Cannabis Use Disorders Identification Test-Revised (CUDIT-R) score
Time Frame: baseline, one month, two months, three months
|
Cannabis Use Disorders Identification Test-Revised (CUDIT-R) will be administered in a group of patients with cannabis addiction to assess cannabis consumption, abuse, dependence, and psychological features.
The questionnaire consists of 7 items scored on a 0-4 scale, and the last question is scored on a three point scale (0-2-4).
Scores of 8 or more indicate hazardous cannabis use, and the cut-off for possible cannabis use disorder is =<12 points.
|
baseline, one month, two months, three months
|
|
Drug Use Disorders Identification Test (DUDIT) score
Time Frame: baseline, one month, two months, three months
|
Drug Use Disorders Identification Test (DUDIT) is an 11-item screening questionnaire measuring drug intake and severity of substance ause and dependence.
Items 1 to 9 are scored on a five-point Likert scale, and items 10 and 11 are scored on a three-point scale (0-2-4).
Scores of 25 points or more are probably indicative of heavy dependence on drugs.
|
baseline, one month, two months, three months
|
|
Hospital Depression and Anxiety Scale (HADS) score
Time Frame: baseline, one month, two months, three months
|
Hospital Anxiety and Depression Scale (HADS) is a 14-item questionnaire with two subscales, each consisting of 7 items.
For both subscales, scores between 8-10 indicate mild depression or anxiety, and scores in the range of 11-21 are indicative of depression or anxiety disorder.
|
baseline, one month, two months, three months
|
|
Difficulties in Emotion Regulation Scale (DERS) score
Time Frame: baseline, one month, two months, three months
|
Emotion regulation will be assessed with Difficulties in Emotion Regulation Scale (DERS), a 36-item questionnaire, rated on a scale from 1 (almost never) to 5 (almost always).
It consists of 6 subscales.
Higher scores suggest greater difficulties in emotion regulation.
|
baseline, one month, two months, three months
|
|
Satisfaction with Life Scale (SWLS) score
Time Frame: baseline, one month, two months, three months
|
Participants' satisfaction with their life will be assessed with The Satisfaction With Life Scale (SWLS), Polish version from Jankowski (2015).
SWLS is a short self-report instrument on which participants indicate their agreement to five statements about life satisfaction on a seven-point Likert scale.
A maximum score of 35 can be reached, indicating a high level of life satisfaction.
|
baseline, one month, two months, three months
|
|
Coping Orientation to Problems Experienced (mini-COPE) score
Time Frame: baseline, one month, two months, three months
|
Coping Orientation to Problems Experienced (mini-COPE) questionnaire measures coping styles used to deal with difficult situations It consists of 28 items and three subscales corresponding to three coping styles.
Higher scores on each of the subscale indicate increased usage of a corresponding coping style.
|
baseline, one month, two months, three months
|
|
Impulsive Behavior Scale (SUPPS) score
Time Frame: baseline, one month, two months, three months
|
Impulsive Behavior Scale (SUPPS) is a 20-item measure of impulsive traits.
It consists of 20 items, with answers ranging from 1 = 'strongly agree' to 4 = 'strongly disagree'.
|
baseline, one month, two months, three months
|
|
Brief Sensation Seeking Scale (BSSS) score
Time Frame: baseline, one month, two months, three months
|
Brief Sensation Seeking Scale (BSSS) is a short, 8-item scale measuring sensation seeking.
Responses are made on a 5-point scale, where higher score indicate stronger agreement.
Higher scores indicate more impulsive behavior.
|
baseline, one month, two months, three months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023/003A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorders
-
University of ArkansasNational Center for Advancing Translational Sciences (NCATS)RecruitingParenting | Substance Use Treatment | Perinatal Substance UseUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Substance Use Disorder (SUD)United States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)Active, not recruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorders | Nicotine Use DisorderUnited States
-
Spark Biomedical, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA); Baylor College... and other collaboratorsRecruitingSubstance Use Disorders | Alcohol Use Disorder | Alcohol Abuse | Substance Use Disorders Alcohol Use Withdrawal StateUnited States
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Substance Use DisordersUnited States
Clinical Trials on Mobile app-based self-guided interventions
-
Universidade Federal do Rio de JaneiroCompleted
-
Universitaire Ziekenhuizen KU LeuvenSidekick HealthCompleted
-
Tan Tock Seng HospitalNanyang Technological University; Geriatric Education and Research InstituteEnrolling by invitationCognitive DeclineSingapore
-
Pakistan Association of Cognitive TherapistsRecruiting
-
Pakistan Association of Cognitive TherapistsWorld Psychiatric Association (WPA)CompletedDepression | AnxietyPakistan
-
Asan Medical CenterNot yet recruitingHypertension | Chronic Disease | Hyperlipidemias | Lifestyle Risk Reduction
-
University of South CarolinaCompleted
-
University of Nevada, Las VegasSanvelloCompletedDepression, AnxietyUnited States
-
Peking UniversityPeking University First HospitalNot yet recruitingGestational Diabetes MellitusChina
-
Goethe UniversityTechnische Universität Dresden; Mindable Health GmbHRecruitingSocial AnxietyGermany